• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    CytoMed Therapeutics Limited - Ordinary Shares (NQ: GDTC )

    1.800 +0.160 (+9.76%)
    Streaming Delayed Price Updated: 3:56 PM EDT, Aug 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,093
    Open 1.650
    Bid (Size) 1.600 (3)
    Ask (Size) 1.800 (6)
    Prev. Close 1.640
    Today's Range 1.610 - 1.800
    52wk Range 1.465 - 5.500
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week! 
    Via InvestorPlace
    CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers
    Another Patent Granted for CytoMed's Allogeneic Induced Pluripotent Stem Cell (“iPSC”)-derived Hybrid Gamma Delta Natural Killer T (γδ NKT) cells technology 
    From CYTOMED THERAPEUTICS LIMITED
    Via GlobeNewswire

    Performance

    YTD
    -59.18%
    -59.18%
    1 Month
    -15.25%
    -15.25%
    3 Month
    -16.67%
    -16.67%
    6 Month
    -14.49%
    -14.49%
    1 Year
    -57.85%
    -57.85%

    More News

    Read More
    Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration
    Via Spotlight Growth
    CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration
    Via ACCESSWIRE
    CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
    From CYTOMED THERAPEUTICS LIMITED
    Via GlobeNewswire
    CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
    From CYTOMED THERAPEUTICS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    US Stocks Gain; Uber Posts Upbeat Sales
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
    From CYTOMED THERAPEUTICS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Singapore’s Journey to Becoming a Biotech Powerhouse
    Via Spotlight Growth
    Topics Economy
    Exposures Economy
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    CytoMed Expands Research Collaboration into China After Entering Into MOU
    Via ACCESSWIRE
    Singapore’s Leap into the Future of Cell and Gene Therapies
    Via Spotlight Growth
    Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
    Via Talk Markets
    The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology
    Via Spotlight Growth
    Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.